Dallas, Texas, Aug. 10, 2017 -- Dr. Lori Stetler and Dr. Kristel Polder, of Dallas Center for Dermatology and Aesthetics, are among the first doctors in Dallas to perform upper arm fat reduction treatment with CoolSculpting, the first and only FDA-cleared technology to address this area of the body. 2
CoolSculpting works by gently cooling targeted fat cells in the body and producing a natural, controlled elimination of these fat cells without affecting surrounding tissue. While CoolSculpting has been used to treat other areas of the body, the recent FDA clearance of its CoolAdvantage™ Petite Applicator makes it the only non-invasive fat removal technology available in the U.S. to address upper arm fat.
“We’ve had a waiting list for months of patients who are ready to say goodbye to their ‘bat wings’,” says Dr. Polder. “Since we offer dual sculpting, we can treat both arms at the same time, and schedule patients for one session that only lasts 35 minutes.”
CoolSculpting is a safe and effective treatment for non-invasive fat reduction. The technology is FDA-cleared for the treatment of fat bulges in the submental (below the chin) area, thigh, abdomen, flank, bra and back fat area, underneath the buttocks and now, the upper arm.
Dr. Stetler explains that CoolSculpting is not a weight-loss treatment. “Each contouring treatment reduces about 20 to 25% of fat cells in the targeted area, and most people require two sessions to achieve their desired results,” says Dr. Stetler. “CoolSculpting is most effective for stubborn pockets of fat that just won’t go away with routine exercise and maintaining a healthy diet.”
Only a select group of dermatologists currently have access to the CoolAdvantage™ Petite Applicator, with a more expanded launch to follow in the coming weeks. CoolSculpting® is developed and marketed by ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ).
About the Dallas Center for Dermatology and Aesthetics
The Dallas Center for Dermatology and Aesthetics, founded in 1991, is located in the Park Cities area of the metropolitan community. Dr. Lori Stetler and Dr. Kristel Polder are board-certified dermatologists, clinical professors, and skin care experts specializing in general medical and cosmetic dermatology, laser procedures, facial rejuvenation, injectables, and non-surgical body contouring.
For more information, please contact:
Suzie Robinson, APR
Atria Public Relations
[email protected] | 214-577-9329
1.) FDA - https://www.accessdata.fda.gov/cdrh_docs/pdf16/K162050.pdf
2.) .CoolSculpting® Announces Only FDA-Cleared Non-Invasive Treatment for Upper Arm Fat - https://globenewswire.com/news-release/2017/01/26/911210/0/en/CoolSculpting-Announces-Only-FDA-Cleared-Non-Invasive-Treatment-for-Upper-Arm-Fat.html
Suzie Robinson The Dallas Center for Dermatology and Aesthetics, 214-5779329 [email protected]


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Instagram Outage Disrupts Thousands of U.S. Users
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



